|1.||Valverde, Ibai E: 1 article (10/2015)|
|2.||Vomstein, Sandra: 1 article (10/2015)|
|3.||Mindt, Thomas L: 1 article (10/2015)|
|4.||Mascarin, Alba: 1 article (10/2015)|
|5.||Seebach, Dieter: 1 article (05/2011)|
|6.||Ebert, Marc-Olivier: 1 article (05/2011)|
|7.||Hübner, Harald: 1 article (05/2011)|
|8.||Gmeiner, Peter: 1 article (05/2011)|
|9.||Reubi, Jean Claude: 1 article (05/2011)|
|10.||Gardiner, James: 1 article (05/2011)|
10/21/2015 - "A "triazole scan" of the peptide sequence yielded novel NT(8-13) analogues with enhanced stability, retained receptor affinity, and improved tumor targeting properties in vivo. "
10/21/2015 - "Its binding sequence, NT(8-13), represents a promising vector for the development of peptidic radiotracers for tumor imaging and therapy. "
09/01/2007 - "Here, we synthesized the neurotensin functional fragment NT(8-13) in a tetrabranched form linked to different units for tumor therapy or diagnosis. "
05/01/2011 - "Neurotensin (NT; 1) and its C-terminal fragment NT(8-13) are ligands of the G-protein-coupled receptors (GPCR) NT1, NT2, NT3, and NT analogs are promising tools to be used in cancer diagnostics and therapy. "
06/24/2010 - "A total of 43 novel derivatives of NT(8-13) were evaluated, with one, ABS212 (1), being most active in four rat models of pain when administered peripherally. "
03/27/2008 - "The central administration of neurotensin (NT) or of its C-terminal hexapeptide fragment NT(8-13), produces strong analgesic effects in tests evaluating acute pain. "
04/18/1995 - "We investigated the functional actions of an analog of NT(8-13), N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1), and other NT related analogs by quantitative measurement of the cytosolic free Ca2+ concentration in HT-29 (human colonic adenocarcinoma) cells using the Ca(2+)-sensitive dye fura-2/AM and by effects on cyclic GMP levels in rat cerebellar slices. "
|2.||G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
|3.||Fura-2 (Fura 2)